Acrivon Therapeutics, Inc. - Common Stock (NQ: ACRV )
6.900
+0.350
(+5.34%)
Streaming Delayed Price
Updated: 12:43 PM EST, Nov 25, 2024
Add to My Watchlist
Headline News about Acrivon Therapeutics, Inc. - Common Stock
Via Benzinga
Acrivon Therapeutics: Q4 Earnings Insights
March 28, 2024
Via Benzinga
Analyst Ratings for Acrivon Therapeutics
November 10, 2023
Via Benzinga
Recap: Acrivon Therapeutics Q3 Earnings
November 09, 2023
Via Benzinga
Analyst Expectations for Acrivon Therapeutics's Future
October 05, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 09, 2024
Via Benzinga
Dow Dips 150 Points; Laser Photonics Shares Spike Higher
April 09, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings
April 09, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 09, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 15, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
August 18, 2023
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 07, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 20, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free